脑膜瘤:X染色体丢失的性别特异性差异及预后意义
该研究基于7424例脑膜瘤样本的DNA甲基化芯片数据及796例样本的靶向测序、临床注释和形态学亚型分析,比较男女患者在突变、甲基化类别、拷贝数变异和組織学上的差异。女性恶性脑膜瘤约占53%,其中57%存在一条X染色体丢失;良性肿瘤中女性约占75%,仅约10%检出X染色体丢失,但与无进展生存期显著更差相关。结论认为性染色体拷贝数状态可用于提高诊断准确性。
要点
- 女性占恶性脑膜瘤约53%,其中57%的恶性病例存在一条X染色体丢失。
- 良性脑膜瘤中女性约占75%,仅约10%检出X染色体丢失。
- 良性肿瘤中X染色体丢失与显著更差的无进展生存期相关。
核心结论
- 尽管基因组不稳定是恶性脑膜瘤的常见特征,但在組織学和分子学上属于低风险的女性患者肿瘤中,X染色体丢失赋予更高风险。
- 性染色体拷贝数状态可用于提高诊断准确性。
研究设计与样本
- 研究分析了7424例脑膜瘤样本的DNA甲基化芯片数据,并对796例样本进行靶向测序、临床注释和形态学亚型分析。
- 比较女性与男性在突变、甲基化类别、拷贝数变异和組織学方面的差异。
主要发现
- 女性恶性脑膜瘤约占53%,其中57%的恶性病例存在一条X染色体丢失。
- 良性肿瘤中女性约占75%,仅约10%的病例检出X染色体丢失。
- 良性肿瘤中X染色体丢失与显著更差的无进展生存期相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningiomas are the most common primary intracranial tumors in adults. Several studies proposed new stratification systems with a more accurate risk prediction than the WHO grading, eg, based on methylation and copy-number variations (CNVs). Yet, common shortcomings in these analyses are either a lack of stratification by sex of patients or excluding the gonosomes from CNV assessment. METHODS: Within this study, DNA methylation array data from 7424 meningioma samples as well as targeted sequencing, clinical annotations, and morphology subtyping of 796 samples were examined for differences between females and males regarding mutations, methylation classes, CNVs, and histology. RESULTS: Meningiomas from females accounted for about 53% of the malignant tumors and present a loss of one X chromosome in 57% of these malignant cases. In the group of benign tumors, females comprised about 75% of the patients. Therein, a loss of one X chromosome was detected in only about 10% of the cases but was associated with a significantly worse progression-free survival. CONCLUSIONS: Although genomic instability is a common feature of malignant meningiomas, particularly loss of the X chromosome in tumors of female patients in otherwise histologically and molecularly low-risk tumors confers higher risk. Hence, the gonosomal copy-number status can be leveraged for increased diagnostic accuracy.
引用
- Berghaus N, Hielscher T, Savran D, et al. Meningiomas: Sex-specific differences and prognostic implications of a chromosome X loss. Neuro Oncol. 2025. PMID: 39535060. doi:10.1093/neuonc/noae239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。